Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder

Urological Research

Volumn 32, Issue 2, 2004, Pages 124-128

  Lekili, Murat ^a   Şener, Ercüment ^a   Demir, Mehmet Akif ^a   Temeltaş, Gökhan ^a   Müezzinoǧlu, Talha ^a   Büyüksu, Coşkun ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Bladder cancer; NMP 22; Tumor marker

Indexed keywords

AUTOCRINE MOTILITY FACTOR RECEPTOR; NUCLEAR MATRIX PROTEIN; NUCLEAR MATRIX PROTEIN 22; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BLADDER CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CONTROLLED STUDY; DIAGNOSTIC VALUE; FIBRINOLYSIS; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; SENSITIVITY ANALYSIS; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR VOLUME; URINALYSIS; URINE CYTOLOGY; URODYNAMICS;

CARCINOMA, TRANSITIONAL CELL; HUMANS; NEOPLASM STAGING; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL; TURKEY; URINARY BLADDER NEOPLASMS;

EID: 3142660275     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-003-0394-2     Document Type: Article

References (28)

1. Lee R, Droller MJ (2000) The natural history of bladder cancer. Urol Clin North Am 27:1-12
2. Abel PD (1988) Prognostic indices in transitional cell carcinoma of the bladder. Brit J Urol 62:103
3. Brown FM (2000) Urine cytology: is it still the gold standard for screening? Urol Clin North Am 27:25-36
4. Korman HJ, Peabody JO, Cerny JC, Farh RN, Yao J, Raz A (1996) Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder. J Urol 155:347
5. Schmetter BS, Habicht KK, Lamm DL, Morales A, Grossman HB, Bander N et al. (1996) Results of a multicenter trial evaluation of Aura-Tek FDP: an aid in the management of bladder cancer patients. J Urol 155:492A
6. Sarosdy MF, De Vere White RW, Soloway MS, Sheinfeld J, Hudson MA, Schellhammer PF et al. (1995) Results of a multicenter trial using BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 154:379
7. Keesee SK, Meneghini MD, Szaro RP, Wu YJ (1994) Nuclear matrix proteins in human colon cancer. Proc Natl Acad Sci U S A 91:1913
8. Khanuja PS, Lehr JE, Soule HD, Gehani SK, Noto AC, Choudhury S et al. (1993) Nuclear matrix proteins in normal and breast cancer cells. Cancer Res 53:3394
9. Bidwell JP, Fey EG, Van Wijnen AJ, Penman S, Stein JL, Lian JB et al. (1994) Nuclear matrix proteins distinguish normal diploid osteoblasts from osteosarcoma cells. Cancer Res 54:28
10. Grocela JA, McDougal WS (2000) Utility of nuclear matrix protein (NMP 22) in the detection of recurrent bladder cancer. Urol Clin North Am 27:47-50
11. Boman H, Hedelin H, Holmang S (2002) Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence. J Urol 167:80-83
12. Hermonek P, Sobin LH (1987) UICC-International Union against Cancer. TNM classification of malignant tumors, 4th edn. Springer-Verlag, Heidelberg
13. Mostofi FK, Sobin LH, Torloni H (1973) Histologic typing of urinary bladder tumors (International Histologic Classification of Tumors No.10). World Health Organization, Geneva
14. Papanicolaou GN, Marshall VF (1945) Urine sediment smears as a diagnostic procedure in cancers of the urinary tract. Science 101:519-520
15. Badalament RA, Hemansen DK, Kimmel M, Gay H, Herr HW, Fair WR et al. (1987) The sensitivity of bladder wash flow cytometry, bladder wash cytology and voided cytology in the detection of bladder carcinoma. Cancer 60:1423
16. Carpinito GA, Stadler WM, Brigmann JV, Chodak GW, Church PA, Lamm DL et al. (1996) Urinary nuclear matrix proteins as a marker for transitional cell carcinoma of the urinary tract. J Urol 156:1280
17. Miyanaga N, Akaza D, Ishikawa T, Ohtani M, Naguchi R, Kawai K et al. (1997) Clinical evaluation of nuclear matrix protein 22 (NMP22) in urine as a novel marker for urothelial cancer. Eur Urol 31:163-168
18. Sözen S, Biri H, Sinik Z, Küpeli B, Alkibay T, Bozkirli (1999) Comparison of the nuclear matrix protein 22 with voided urine cytology and BTA stat test in the diagnosis of transitional cell carcinoma of the bladder. Eur Urol 36:225-229
19. Soloway MS, Brigmann JV, Carpinito GA, Chodak GW, Church PA, Lamm DL et al. (1996) Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol 156:363-367
20. Stampfer DS, Carpinito GA, Rodriguez-Villanueva J et al. (1998) Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder. J Urol 159:394-398
21. Wiener HG, Mian C, Haitel A et al. Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer? J Urol 159:1876-1880
22. Ramakumar S, Bhuiyan J, Besse JA et al. (1999) Comparison of screening methods in the detection of bladder cancer. J Urol 161:388-394
23. Del Nero A, Esposito N, Currò A et al. (1999) Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer: comparison with urinary cytology and BTA test. Eur Urol 35:93-97
24. Sanchez-Carbayo M, Herrero E, Megias J et al. (1999) Evaluation of nuclear matrix protein 22 as a tumour marker in the detection of transitional cell carcinoma of the bladder. Br J Urol 84:706-713
25. Casella R, Huber P, Blöchlinger A et al. (2000) Urinary level of NMP 22 in the diagnosis of bladder cancer: experience with 130 patients with biopsy confirmed tumor. J Urol 164:1926-1928
26. Ooms EC, Anderson WA, Alons CL, Boon ME, Veldhuizen RW (1983) Analysis of the performance of pathologists in the grading of bladder tumors. Hum Pathol 14:140
27. Renshaw AA, Nappi D, Weinberg DS (1996) Cytology of grade 2 papillary transitional cell carcinoma: a comparison of cytologic, architectural and morphometric criteria in cystopically obtained urine. Acta Cytol 40:676-682
28. Wiener HG, Vooijs GP, Van't Hof-Grootenboer B (1993) Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 37:163